Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 302 results
A minimalist illustration of a cancer cell and imaging system on a dark background.

Jun 5, 2026

AI-Powered Imaging Systems and Deep Learning Software Revolutionize Cancer Diagnostics Market Globally

The AI in cancer diagnostics market is poised for significant growth, driven by advancements in technology and increasing demand for early detection solutions.According to recent projections, the market is expected to increase from $0.79 billion in 2025 to $0.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.2%. This growth is attributed to the rising incidence of cancer globally, with the National Cancer Institute forecasting 2 million new cases in the U.S. by 2024 and 29
Minimalist representation of a PD-L1 antibody

Jun 5, 2026

AI collaboration to advance digital pathology

Leica Biosystems, Indica Labs, and Lunit have announced a strategic partnership aimed at enhancing digital pathology through AI-powered image analysis algorithms, particularly for PD-L1 and other immunohistochemistry biomarkers.This collaboration builds on an existing relationship between Leica Biosystems and Indica Labs, now integrating Lunit’s advanced AI technology into a comprehensive digital pathology ecosystem. The initial product from this partnership is the Lunit SCOPE algorithm, designe
Flat design of a radiology report with an imaging insight icon

Jun 3, 2026

Cortechs.ai, Microsoft Collaborate to Bring AI-Powered Imaging Insights into Radiology Workflows

Cortechs.ai has entered into a strategic partnership with Microsoft to enhance radiology workflows through the integration of AI-powered imaging insights and biomarkers. This initiative aims to improve diagnostic accuracy, streamline reporting processes, and expedite clinical decision-making across healthcare settings.The collaboration seeks to embed Cortechs.ai's quantitative imaging applications into Microsoft's existing radiology reporting tools, allowing clinicians to access valuable imaging
A blood smear on a microscope slide in a lab setting

Jun 3, 2026

AI-Powered Pathology Research Advances Diagnostics In South Africa

The National Health Laboratory Service (NHLS) in South Africa is embarking on an ambitious initiative to integrate artificial intelligence (AI) into pathology research, aiming to enhance diagnostic accuracy and efficiency within the public healthcare system.This initiative is part of a broader strategy to modernize laboratory medicine, with a particular focus on haematopathology. Traditionally, diagnosing conditions like multiple myeloma has been labor-intensive and subject to variability, espec
Flat design of TROP2 biomarker and assay

Jun 3, 2026

Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics

Leica Biosystems is enhancing its collaboration with AstraZeneca and Daiichi Sankyo to advance precision medicine through the development of AI-driven diagnostics for non-small cell lung cancer.The expansion of this partnership, initially established in May 2025, focuses on the creation of an immunohistochemistry (IHC) assay and image analysis algorithm targeting the TROP2 Normalized Membrane Ratio (NMR) biomarker. This initiative aims to provide a comprehensive research tool that integrates bot
Microscope and tissue sample illustration

Jun 2, 2026

GLOBAL PATHOLOGY, DIAGNOSTICS & LABORATORY MEDICINE CONFERENCE & BUSINESS EXPO: INNOVATION, INVESTMENT, AND INDUSTRY PARTNERSHIPS

The upcoming Global Pathology, Diagnostics & Laboratory Medicine Conference & Business Expo in 2026 aims to unite professionals from various sectors within the life sciences industry, including pathologists, researchers, and healthcare providers. This event is set to be a significant platform for discussing advancements and innovations in pathology and diagnostics.The conference will feature a range of activities such as keynote speeches, scientific presentations, and interactive workshops. Thes
A flat illustration of a chest CT scan and lungs in a minimalist style.

Jun 1, 2026

contextflow: MedTech Giant 4DMedical Acquires Vienna Startup for More Than €11.4 Million

4DMedical Limited has announced the acquisition of the Vienna-based startup contextflow for over €11.4 million, marking a strategic expansion into the European market.Founded in 2016, contextflow specializes in AI-driven software for lung diagnostics, focusing on conditions like lung cancer and COPD. Its flagship product, ADVANCE Chest CT, utilizes proprietary AI to analyze chest CT scans, aiding healthcare professionals in disease detection and management. The startup has garnered attention for
A cardiologist's hands holding a stent in an operating room

Jun 1, 2026

Andhra-Based Sri Datta Hospital Completes AI-Guided OCT Stent Implantation

Sri Datta Hospital in Andhra Pradesh has achieved a significant milestone by successfully performing the first AI-guided Optical Coherence Tomography (OCT) stent implantation in the region.This groundbreaking procedure involved the implantation of a Bio-Resorbable Scaffold (BRS) stent in a 60-year-old patient, marking a notable advancement in cardiovascular care. Dr. Krishnakanth Garlapati, a leading interventional cardiologist and the hospital's founder, conducted the operation using an innovat
A minimalist representation of a cell membrane highlighting the TROP2 biomarker in a dark color scheme.

May 31, 2026

Leica Biosystems Expands AstraZeneca And Daiichi Sankyo Collaboration To Advance AI Driven Lung Cancer Biomarker Research

Leica Biosystems is enhancing its collaboration with AstraZeneca and Daiichi Sankyo to further AI-driven research in lung cancer biomarkers, specifically targeting the TROP2 biomarker in non-small cell lung cancer.The expanded partnership aims to develop an immunohistochemistry (IHC) assay and an image analysis algorithm to evaluate the TROP2 Normalized Membrane Ratio (NMR). This initiative builds on AstraZeneca’s existing computational pathology algorithm, Quantitative Continuous Scoring (QCS),
Minimalist illustration of a liver with AI elements

May 31, 2026

Roche Holding AG stock (CH0012032048): Liver disease AI panel and diagnostics push keep Swiss shares

Roche Holding AG has garnered attention on the SIX Swiss Exchange following the introduction of an AI-enabled Liver Disease Panel by its diagnostics division. This launch is part of a broader strategy to enhance its product offerings in 2026, which is crucial for investors monitoring the company's growth trajectory and innovation in healthcare technology.The newly unveiled Liver Disease Panel leverages certified algorithms aimed at improving the management of chronic liver diseases, marking anot
A radioconjugate vial on a lab bench in a clinical setting.

May 29, 2026

Nucs AI Announces Collaboration to Develop AI-driven Response Prediction for Next-Generation Therapeutic Radioconjugates

Nucs AI has partnered with AstraZeneca to enhance predictive imaging biomarkers for therapeutic radioconjugates, specifically targeting metastatic prostate cancer.This collaboration marks a significant step in the pharmaceutical industry's exploration of AI-driven response prediction models. Nucs AI aims to adapt its existing technology to create predictive models tailored for next-generation PSMA-targeted radioconjugates. By focusing on metastatic castration-resistant prostate cancer, the partn
Flat design illustration of lung and breast cancer cells

May 29, 2026

AstraZeneca & Roche Push AI-Based Cancer Pathology Expansion Across Asia

AstraZeneca and Roche Diagnostics Asia Pacific have embarked on a significant collaboration aimed at enhancing AI-driven cancer pathology across multiple Asian countries. This three-year initiative will specifically target Singapore, Taiwan, South Korea, Thailand, Malaysia, India, Indonesia, Vietnam, and the Philippines.The partnership seeks to advance biomarker testing and facilitate more precise treatment options for patients with breast and lung cancer. AstraZeneca and Roche plan to implement